Skip Navigation



Rheumatology Advance Access published online on March 17, 2008

Rheumatology, doi:10.1093/rheumatology/ken028
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/609    most recent
ken028v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Iking-Konert, C.
Right arrow Articles by Hänsch, G. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iking-Konert, C.
Right arrow Articles by Hänsch, G. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

T lymphocytes in patients with primary vasculitis: expansion of CD8 + T cells with the propensity to activate polymorphonuclear neutrophils

C. Iking-Konert1, T. Vogl1, B. Prior2, C. Wagner3, O. Sander1, E. Bleck1, B. Ostendorf1, M. Schneider1, K. Andrassy4 and G. M. Hänsch2

1Rheumatology, Department of Endocrinology, Diabetology and Rheumatology, Heinrich-Heine-University of Duesseldorf, 2Institute for Immunology, Ruprecht-Karls University of Heidelberg, 3Klinik für Unfallchirurgie und Orthopädie, Berufsgenossenschaftliche Unfallklinik Ludwigshafen and 4Medizinische Klinik, Ruprecht-Karls University of Heidelberg, Germany.

Correspondence to: C. Iking-Konert, Rheumatology, Department of Endocrinology, Diabetology and Rheumatology, Heinrich-Heine-University of Duesseldorf, Moorenstr 5, 40225 Düsseldorf, Germany. E-mail: Iking-konert{at}med.uni-duesseldorf.de


   Abstract

Objectives. To gain insight into the immune pathogenesis of primary ANCA-associated vasculitides, the prevalence of circulating T lymphocytes expressing CD11b as a marker for activation was analysed in patients with WG or microscopic polyangiitis.

Methods. Receptor expression and IFN{gamma} synthesis were measured in T cells of patients with active disease by cytofluorometry and compared with expression in patients in remission and in healthy donors.

Results. During active disease, a small but conspicuous population of CD8+CD28+CD11b+ was found which produced IFN{gamma}. In healthy donors and in patients in remission or undergoing immunosuppressive therapy, CD11b was exclusively associated with CD8+CD28– cells, the latter being more frequent in patients with long-lasting or severe disease. In vitro experiments confirmed that CD11b is up-regulated when T cells are activated. After multiple rounds of restimulation, the CD11b expression persists whereas CD28 expression is lost, compatible with the notion that CD8+CD28+CD11b+ represents a transient phenotype in the course of T-cell activation. The IFN{gamma}-producing T cells activated polymorphonuclear neutrophils (PMN) to express MHC class II, thus generating the same PMN phenotype as in patients with active ANCA-associated vasculitis. A similar PMN phenotype could be generated by cultivation with supernatants of activated T cells or by IFN{gamma} alone, but not by antibodies to proteinase 3.

Conclusions. In active primary vasculitis, a small population of CD8+ T cells, identified by the expression of CD11b, expands, producing IFN{gamma}. These T cells could activate PMN, thus generating a long-living and potentially destructive PMN phenotype.

KEY WORDS: PMN, ANCA, Vasculitis, T cells, CD11b, CD28, CD8, WG, Microscopic polyangiitis

Submitted 5 September 2007; revised version accepted 11 January 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.